Powder: | Yes |
---|---|
Customized: | Customized |
Certification: | GMP, HSE, ISO 9001, USP, BP |
Suitable for: | Elderly, Children, Adult |
State: | Solid |
Purity: | >99% |
Samples: |
---|
Customization: |
---|
Suppliers with verified business licenses
Product Name | Enzalutamide |
CAS NO. | 915087-33-1 |
Purity | 99% |
Density | 1.49 |
Appearance and shape | White powder |
Function
1.Enzalutamide is clinically effective in the treatment of mCRPC.
2.Treatment of metastatic castration resistant prostate cancer.
3.Enzalutamide can be used as an antiandrogen in feminizing hormone therapy for transgender women.
Application
Enzalutamide (XTANDI, enzalutamide) is an oral androgen receptor antagonist. It is currently clinically studied and approved by the US FDA (Food and Drug Administration) Chemicalbook for use in metastatic castration-resistant prostate cancer that has progressed after chemotherapy. The treatment of prostate cancer (that is, patients with prostate cancer whose tumor or cancer cells are still growing after chemotherapy) can prolong the survival time of the patient.
Suppliers with verified business licenses